Paul Chinn

663 total citations
11 papers, 532 citations indexed

About

Paul Chinn is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Paul Chinn has authored 11 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in Paul Chinn's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Paul Chinn is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Paul Chinn collaborates with scholars based in United States, Mexico and Switzerland. Paul Chinn's co-authors include Nabil Hanna, Susan J. Knox, Carol Marquez, Nimisha Deb, Antonio J Grillo-López, Mark Becker, Ronald Levy, Kirk Trisler, Michael L. Goris and C. Varns and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Paul Chinn

11 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Chinn United States	8	365	244	140	89	88	11	532
Kirk Trisler United States	9	383 1.0×	186 0.8×	160 1.1×	225 2.5×	63 0.7×	13	576
Don B. Axworthy United States	11	524 1.4×	204 0.8×	134 1.0×	85 1.0×	39 0.4×	14	634
SJ Knox United States	12	387 1.1×	138 0.6×	142 1.0×	117 1.3×	111 1.3×	21	586
Olga Ab United States	11	398 1.1×	79 0.3×	577 4.1×	42 0.5×	73 0.8×	23	776
G. Rowlinson United Kingdom	7	285 0.8×	53 0.2×	122 0.9×	49 0.6×	46 0.5×	10	435
Katharine C. Lai United States	8	342 0.9×	67 0.3×	426 3.0×	20 0.2×	65 0.7×	17	590
E Barendswaard United States	10	336 0.9×	63 0.3×	177 1.3×	150 1.7×	57 0.6×	11	626
Denise Darrah United States	10	102 0.3×	67 0.3×	240 1.7×	53 0.6×	143 1.6×	16	423
Elena Luison Italy	15	224 0.6×	37 0.2×	166 1.2×	73 0.8×	107 1.2×	22	532
Patrick H. van Berkel United Kingdom	9	181 0.5×	113 0.5×	393 2.8×	23 0.3×	96 1.1×	35	496

Countries citing papers authored by Paul Chinn

Since Specialization

Citations

This map shows the geographic impact of Paul Chinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Chinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Chinn more than expected).

Fields of papers citing papers by Paul Chinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Chinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Chinn. The network helps show where Paul Chinn may publish in the future.

Co-authorship network of co-authors of Paul Chinn

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Chinn. A scholar is included among the top collaborators of Paul Chinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Chinn. Paul Chinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Zhang, Jianping, Abiche H. Dewilde, Paul Chinn, et al.. (2011). Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cellsin vitrovia hyperthermia. International Journal of Hyperthermia. 27(7). 682–697. 37 indexed citations

Vega, Mario I., Sara Huerta‐Yépez, Melisa Martinez-Paniagua, et al.. (2009). Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions. Clinical Cancer Research. 15(21). 6582–6594. 47 indexed citations

Hoopes, P. Jack, Jennifer A. Tate, Steven Fiering, et al.. (2009). Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7181. 71810P–71810P. 11 indexed citations

Chinn, Paul, et al.. (2006). Pharmacokinetics and Tumor Localization of ¹¹¹ In-Labeled HuCC49ΔC _H 2 in BALB/c Mice and Athymic Murine Colon Carcinoma Xenograft. Cancer Biotherapy and Radiopharmaceuticals. 21(2). 106–116. 12 indexed citations

Vega, Mario I., Sara Huerta‐Yépez, Paul Chinn, et al.. (2004). Rituximab-Mediated Molecular Cell Signaling Via CD20 in B-NHL Cell Lines: Autonomy from Cross-Linking with Tumor FcRs.. Blood. 104(11). 3404–3404. 2 indexed citations

Chinn, Paul, Gary R. Braslawsky, Christine White, & Nabil Hanna. (2003). Antibody therapy of non-Hodgkin's B-cell lymphoma. Cancer Immunology Immunotherapy. 52(5). 257–280. 30 indexed citations

Nakamura, Takehiko, William S. Kloetzer, Peter Brams, et al.. (2000). In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. International Journal of Immunopharmacology. 22(2). 131–141. 41 indexed citations

Chinn, Paul, John E. Leonard, J. Rosenberg, Nabil Hanna, & David R. Anderson. (1999). Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma.. International Journal of Oncology. 15(5). 1017–25. 71 indexed citations

Witzig, Thomas E., Christine A. White, A.J. Grillo-López, et al.. (1998). Radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma (NHL) with IDEC-Y2B8. International Journal of Radiation Oncology*Biology*Physics. 42(1). 130–130. 2 indexed citations

10.

Knox, Susan J., Michael L. Goris, Kirk Trisler, et al.. (1996). Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.. PubMed. 2(3). 457–70. 273 indexed citations

11.

Knox, Susan J., Michael L. Goris, Kirk Trisler, et al.. (1995). 148 90Y-anti-CD20 monoclonal antibody therapy for recurrent B cell lymphoma. International Journal of Radiation Oncology*Biology*Physics. 32. 215–215. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact